Globus Medical Revenue vs. Current Valuation

GMED Stock  USD 82.63  0.69  0.84%   
Taking into consideration Globus Medical's profitability measurements, Globus Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Globus Medical's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
629.7 M
Current Value
625.7 M
Quarterly Volatility
133.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Globus Medical's Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's EV To Sales is expected to grow to 4.00, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.45. At present, Globus Medical's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 44.9 M, whereas Income Before Tax is forecasted to decline to about 162.4 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.850.6505
Significantly Up
Slightly volatile
Net Profit Margin0.07440.0783
Notably Down
Slightly volatile
Operating Profit Margin0.08060.0849
Notably Down
Slightly volatile
Pretax Profit Margin0.10.1054
Notably Down
Slightly volatile
Return On Assets0.0230.0242
Notably Down
Slightly volatile
Return On Equity0.02920.0307
Notably Down
Slightly volatile
For Globus Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Globus Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Globus Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Globus Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Globus Medical over time as well as its relative position and ranking within its peers.
  

Globus Medical's Revenue Breakdown by Earning Segment

Check out Risk vs Return Analysis.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
42.231
Earnings Share
0.62
Revenue Per Share
18.217
Quarterly Revenue Growth
0.631
Return On Assets
0.0473
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Globus Medical Current Valuation vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Globus Medical's current stock value. Our valuation model uses many indicators to compare Globus Medical value to that of its competitors to determine the firm's financial worth.
Globus Medical is rated # 5 in revenue category among its peers. It is rated # 4 in current valuation category among its peers reporting about  7.07  of Current Valuation per Revenue. At present, Globus Medical's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Globus Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Globus Revenue vs. Competition

Globus Medical is rated # 5 in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 214.57 Billion. Globus Medical maintains roughly 1.57 Billion in revenue contributing less than 1% to equities under Health Care industry.

Globus Current Valuation vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Globus Medical

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.57 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Globus Medical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
11.09 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Globus Current Valuation vs Competition

Globus Medical is rated # 4 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 188.12 Billion. Globus Medical holds roughly 11.09 Billion in current valuation claiming about 6% of equities under Health Care industry.

Globus Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Globus Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Globus Medical will eventually generate negative long term returns. The profitability progress is the general direction of Globus Medical's change in net profit over the period of time. It can combine multiple indicators of Globus Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-10.2 M-9.7 M
Operating Income133.1 M153.7 M
Income Before Tax165.4 M162.4 M
Total Other Income Expense Net32.3 M33.9 M
Net Income122.9 M117.5 M
Income Tax Expense42.5 M44.9 M
Net Income Applicable To Common Shares218.7 M120.8 M
Net Income From Continuing Ops122.9 M131.6 M
Non Operating Income Net Other17.3 M18.2 M
Interest Income20.1 M21.1 M
Net Interest Income20.1 M13.5 M
Change To Netincome26 M34.2 M
Net Income Per Share 1.09  0.90 
Income Quality 1.98  1.05 
Net Income Per E B T 0.74  0.57 

Globus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Globus Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Globus Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Globus Medical's important profitability drivers and their relationship over time.

Use Globus Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Globus Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Globus Medical will appreciate offsetting losses from the drop in the long position's value.

Globus Medical Pair Trading

Globus Medical Pair Trading Analysis

The ability to find closely correlated positions to Globus Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Globus Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Globus Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Globus Medical to buy it.
The correlation of Globus Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Globus Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Globus Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Globus Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Globus Medical position

In addition to having Globus Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large & Mid Caps ETFs Thematic Idea Now

Large & Mid Caps ETFs
Large & Mid Caps ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
To fully project Globus Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Globus Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Globus Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Globus Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Globus Medical investors may work on each financial statement separately, they are all related. The changes in Globus Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Globus Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.